Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Over the last decade, chronic inflammatory enteropathies (CIE) in dogs have received great
attention in the basic and clinical research arena. The 2010 ACVIM Consensus Statement …

Background and aims: Mucosal healing in ulcerative colitis (UC) has become a common
endpoint in most clinical trials and a relevant therapeutic goal in clinical practice. Despite …

Background and Aims Assessment of disease activity is essential for developing and
determining appropriate therapy in patients with ulcerative colitis (UC). Validated clinical …

Background The objective was to assess the long-term effect of biological treatment on
transmural lesions of Crohn's disease evaluated with ultrasound, including contrast …

Background and Aims Mucosal healing is an important treatment end-point in inflammatory
bowel disease, and achieving mucosal healing has been demonstrated to improve disease …

Abstract Background and Aims: Safety and efficacy of budesonide multimatrix, an oral
extended-release second-generation corticosteroid designed for targeted delivery …

Abstract Background Faecal calprotectin [FCal] levels are used as a surrogate marker for
mucosal inflammation, but thresholds for defining endoscopic or histological disease activity …

Crohn's disease (CD) and ulcerative colitis (UC) have a chronic-remittent course. Optimal
management of inflammatory bowel diseases (IBD) relies on early intervention, treat-to …

Background & Aims Anemia is a common manifestation of inflammatory bowel disease (IBD)
that can greatly affect patients' quality of life. We performed a prospective study of a large …